Corcept Therapeutics (CORT) had the highest return last month by a mid-cap US stock, returning 86.1%.

ASSET	MONTH	% RETURN
Corcept Therapeutics (CORT)	March 2025	86.06%
Liberty Global PLC Class B (LBTYB)	March 2025	69.71%
Soleno Therapeutics (SLNO)	March 2025	46.02%
Harmony Gold Mining (HMY)	March 2025	44.66%
D-Wave Quantum (QBTS)	March 2025	36.2%
Celsius (CELH)	March 2025	35.95%
Sibanye Gold Ltd ADR (SBSW)	March 2025	35.91%
New Gold (NGD)	March 2025	34.91%
Orla Mining (ORLA)	March 2025	32.62%
TG Therapeutics (TGTX)	March 2025	30%
Concentrix (CNXC)	March 2025	22.91%
Sandstorm Gold Ltd N (SAND)	March 2025	20.99%
First Majestic Silver (AG)	March 2025	20.76%
ADMA Biologics (ADMA)	March 2025	20.61%
Compania de Minas Buenaventura SAA ADR (BVN)	March 2025	20.6%
Veren (VRN)	March 2025	20.36%
Eldorado Gold (EGO)	March 2025	19.72%
Alignment Healthcare LLC (ALHC)	March 2025	19.36%
John Wiley & Sons B (WLYB)	March 2025	19.23%
Worthington Industries (WOR)	March 2025	18.7%
Protagonist Therapeutics (PTGX)	March 2025	18.5%
Kanzhun Ltd ADR (BZ)	March 2025	18.26%
Millrose Properties (MRP)	March 2025	17.72%
Genius Sports (GENI)	March 2025	16.26%
Millicom International Cellular (TIGO)	March 2025	15.89%

Mid-cap stocks are treated as having a market cap between $2B and $10B.